Human Blood for Research Utilizing Malaria Parasite Cultures FY25-0423
Summary
AI-generated · Nov 11, 2025Sole-source negotiation with ZenBio Inc. to provide regular, scheduled deliveries of screened human blood products required for malaria vaccine research at the Walter Reed Army Institute of Research.
All products must be tested for transfusion-transmitted infections per 21 CFR 310.40, FDA-certified, and accompanied by a Certificate of Analysis. Each unit must be certified for HIV-1/2, HBV, HCV, HTLV-I/II, T. pallidum (syphilis), T. cruzi (Chagas), West Nile virus, and Zika virus, and the supplies must be not proprietary.
The Defense Health Agency Contracting Activity (DHACA) R&D Branch 1 intends to negotiate on a sole source basis, IAW 41 United Stated Code 1901 as implemented in FAR 13.501 to ZenBio Inc., 3920 Sount Alston Ave, Durham NC 27713, as the only responsible source that can provide the Walter Reed Army Institute of Research (WRAIR), with regular, scheduled, supply deliveries of screened human blood products that meet the Governments requirements in support of malaria vaccine research. All human blood products provided will have been tested in accordance with 21 Code of Federal Regulations (CFR) Part 310.40 General Biological Products Standards Testing Requirements for Relevant Transfusion-Transmitted Infections and each unit of blood/serum will be FDA certified and accompanied with a Certificate of Analysis (CoA). The screened human blood products provided must be certified to have been tested, at a minimum, for Human Immunodeficiency virus, type 1, 2 (HIV), Hepatitis B virus (HBV), Hepatitis C virus (HCV), Human T-lymphotropic virus, type I,2 (HTLV), Syphilis (T. pallidum), Chagas (T. cruzi), West Nile virus and Zika virus, in order to meet malaria research requirements. Not proprietary.
From Special Notice posted on Nov 10, 2025Notice history
1Details
Award Information
Not yet awarded
Contacts
Phone
Agency
Place of Performance
USA